Valuation Daebongls.Co.,Ltd.

Stocks

End-of-day quote Korea S.E. Other stock markets 10/06/2026			5-day change	1st Jan Change
8,240.00 ^KRW	-0.24%		-4.19%	-29.27%

15/05	Daebongls.Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
23/03	Daebongls.Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	1,23,061	93,238	88,582	1,01,553	1,49,004	1,29,159
Change	-	-24.23%	-4.99%	14.64%	46.72%	-13.32%
Enterprise Value (EV) ¹	58,516	40,899	24,595	59,819	1,26,969	1,41,131
Change	-	-30.11%	-39.86%	143.21%	112.26%	11.15%
P/E Ratio	21.1x	13.6x	10.1x	24x	20.1x	13.5x
PBR	1.18x	0.84x	0.75x	0.83x	1.12x	0.9x
PEG	-	0.8x	0.4x	-0.5x	0.3x	0.5x
Capitalization / Revenue	1.61x	1.12x	0.95x	1.16x	1.59x	1.27x
EV / Revenue	0.77x	0.49x	0.26x	0.68x	1.35x	1.38x
EV / EBITDA	5.46x	3.24x	2.18x	8.31x	10.3x	11.9x
EV / EBIT	7.2x	4.22x	3.01x	15.7x	14.2x	19.2x
EV / FCF	7.76x	-122x	-13.8x	-12.9x	-17.6x	-3.07x
FCF Yield	12.9%	-0.82%	-7.25%	-7.77%	-5.67%	-32.6%
Dividend per Share ²	50	50	50	50	50	-
Rate of return	0.45%	0.59%	0.63%	0.55%	0.37%	-
EPS ²	526	619	788	382	670	864
Distribution rate	9.51%	8.08%	6.35%	13.1%	7.46%	-
Net sales ¹	76,255	82,957	93,504	87,622	93,954	1,02,064
EBITDA ¹	10,717	12,623	11,289	7,199	12,361	11,812
EBIT ¹	8,122	9,685	8,174	3,801	8,966	7,332
Net income ¹	5,821	6,789	8,628	4,182	7,339	10,059
Net Debt ¹	-64,545	-52,339	-63,987	-41,734	-22,034	11,972
Reference price ²	11,100.00	8,410.00	7,990.00	9,160.00	13,440.00	11,650.00
Nbr of stocks (in thousands)	11,087	11,087	11,087	11,087	11,087	11,087
Announcement Date	22/03/21	21/03/22	21/03/23	20/03/24	21/03/25	23/03/26

¹KRW in Million²KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
DAEBONGLS.CO.,LTD.	-	-	-	-	6.01Cr
ELI LILLY AND COMPANY	33.25x	12.09x	24.89x	0.6%	1,01300Cr
JOHNSON & JOHNSON	25.49x	5.87x	15.97x	2.24%	57TCr
ABBVIE INC.	27.54x	6.71x	13.71x	3.05%	40TCr
ROCHE HOLDING AG	17.38x	4.29x	10.55x	3.1%	32TCr
ASTRAZENECA PLC	22.74x	4.73x	13.45x	1.85%	28TCr
NOVARTIS AG	20.72x	5.35x	13x	3.04%	27TCr
AMGEN INC.	21.96x	5.91x	10.33x	2.99%	18TCr
NOVO NORDISK A/S	12.52x	4.69x	9.6x	4.01%	19TCr
GILEAD SCIENCES, INC.	-43.47x	5.27x	29.72x	2.67%	15TCr
Average	15.35x	6.10x	15.69x	2.62%	33.89TCr
Weighted average by Cap.	22.66x	7.45x	17.35x	2.12%